China Pharma Holdings (CPHI) Accumulated Expenses (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Accumulated Expenses came in at $311336.0 in Q1 2026, down 80.49% YoY from $1.6 million in Q1 2025, and down 11.21% on a QoQ basis from $350643.0 in Q4 2025.
China Pharma Holdings (CPHI) Accumulated Expenses (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Accumulated Expenses data on file, last reported at $311336.0 in Q1 2026.
- Quarterly Accumulated Expenses fell 80.49% year-over-year to $311336.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $311336.0 (down 80.49% YoY) and the FY2025 annual result came in at $350643.0, up 41.87% from the prior year.
- Accumulated Expenses fell to $311336.0 in Q1 2026, from $350643.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.6 million in Q3 2025 to a low of $110387.0 in Q2 2022.
- A 5-year average of $486814.0 and a median of $208831.0 in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Accumulated Expenses soared 1291.8% — and 2026, when it tumbled 80.49%.
- Tracing CPHI's Accumulated Expenses over 5 years: stood at $404807.0 in 2022, then surged by 210.15% to $1.3 million in 2023, then tumbled by 80.31% to $247159.0 in 2024, then soared by 41.87% to $350643.0 in 2025, then slipped by 11.21% to $311336.0 in 2026.
- The last three Accumulated Expenses figures came in at $311336.0 (Q1 2026), $350643.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 311,336.00 |
| Dec 31, 2025 | 350,643.00 |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 191,293.00 |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 247,159.00 |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 208,831.00 |
| Mar 31, 2024 | 114,636.00 |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 119,669.00 |
| Jun 30, 2023 | 120,563.00 |
| Mar 31, 2023 | 113,750.00 |
| Dec 31, 2022 | 404,807.00 |
| Sep 30, 2022 | 126,519.00 |
| Jun 30, 2022 | 110,387.00 |
| Mar 31, 2022 | 138,221.00 |
| Dec 31, 2021 | 298,452.00 |
| Sep 30, 2021 | 227,416.00 |
| Jun 30, 2021 | 332,393.00 |